Under the patronage of Dr. Mustafa Madbouly, the Prime Minister, the conference “Medicine and Health Care in the New Republic”, which is currently held in Cairo, held a special session entitled “Ensuring the provision of medicine in light of the global challenges”, with the participation of the Unified purchase authority, the Egyptian Medicine Authority, and the city of medicine.
In contrast, Dr.
Vice-President of the Egyptian Medicine Authority Ayman Al-Khatib stated that during the Korona pandemic, there was no drug crisis and that there was no drug available anywhere else in the world except for Egypt. He added that our guiding principle was that since we were in a crisis, a drug had to be made available, and that the first vaccine appeared at the end of 2020 with the approval of the emergency use of the vaccine, which is the Chinese Senovarim.
For his part, Dr. Hisham State, Vice-Chairman of the Unified Purchase Body, stated that the establishment of the unified purchase body coincided with the start of the Corona pandemic in early 2020. The authority was able, despite the modernity of its establishment, to provide medications and supplies for battling the Corona pandemic, as well as all types of vaccines for the Corona virus, at a time coincided with the vaccination programme used in major countries.
The challenges are reflected in external challenges like global supply chain disruption, high shipping costs, developments in the Russian-Ukrainian war and their impact on the high prices of production inputs for all imported goods, the rise in the cost of import, and internal challenges that were the cause of this reflected in changing the dollar exchange rate, leading to the high prices All the imported inputs on the local product of medicines and other goods.
The authority had plans to address difficulties:
1. An adaptable pricing strategy
2. Providing more than one substitute for a single product, whether it is domestic or imported
3. promoting the intensification of local industrialization of supplies, equipment, and preparations
4. Access to a variety of sources for devices, supplies, and medications
5. Increase the strategic product medicine inventory.
6.
putting medical technology management and health economics concepts into practise to increase the effectiveness of the best use of state health resources.
7. Adopting the digital transformation initiatives to provide the information necessary for planning to provide the drug according to the needs..
The Unified Purchase Authority: During the Korona pandem, the Egyptian citizen did not experience a medicine shortage.
About Author
